BLTE - BELITE BIO, INC

QQQ $ 429.07 $ 5.38 (1.28 %)

DIA $ 382.31 $ 3.34 (0.88 %)

SPY $ 505.01 $ 4.68 (0.94 %)

TLT $ 88.87 $ 0.38 (0.43 %)

GLD $ 213.12 $ -0.66 (-0.31 %)

Previous Close

$ 41.1

Open

$ 40.62

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 39.45 - $ 41.51

52 Week Range

$ 11.00 - $ 48.60

Volume

30,715

Average Volume

Market Cap

1.09B

Beta (5Y Monthly)

$ -0.31

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Reported Earlier, Belite Bio Secures $25M ...
04/26/2024 07:03:21

Belite Bio entered into a securities purchase agreement with an institutional investor, for the purchase and sale of up to an a...

HC Wainwright & Co. Maintains Buy on Belit...
03/22/2024 15:13:22

HC Wainwright & Co. analyst Yi Chen maintains Belite Bio (NASDAQ:BLTE) with a Buy and maintains $59 price target.

Belite Bio Announces PMDA Submission of Ti...
03/22/2024 12:01:41

Belite Bio, Inc (NASDAQ:BLTE) ("Belite Bio" or the "Company"), a clinical-stage biopharmaceutical drug developm...

HC Wainwright & Co. Reiterates Buy on Beli...
03/13/2024 11:00:15

HC Wainwright & Co. analyst Yi Chen reiterates Belite Bio (NASDAQ:BLTE) with a Buy and maintains $59 price target.

Belite Bio Q4 EPS $(0.25) Beats $(0.30) Es...
03/12/2024 05:59:12

Belite Bio (NASDAQ:BLTE) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.30) by...

HC Wainwright & Co. Reiterates Buy on Beli...
12/27/2023 16:45:25

HC Wainwright & Co. analyst Yi Chen reiterates Belite Bio (NASDAQ:BLTE) with a Buy and maintains $59 price target.

Expert Ratings for Belite Bio
12/14/2023 17:00:25

Maxim Group Initiates Coverage On Belite B...
12/14/2023 14:11:50

Maxim Group analyst Jason McCarthy initiates coverage on Belite Bio (NASDAQ:BLTE) with a Buy rating and announces Price Targ...

Belite Bio Received Approval To Initiate T...
12/10/2023 17:45:20

Belite Bio, Inc (NASDAQ:BLTE), a clinical stage biopharmaceutical drug development company focused on advancing novel therapeut...

HC Wainwright & Co. Reiterates Buy on Beli...
11/15/2023 12:05:24

HC Wainwright & Co. analyst Yi Chen reiterates Belite Bio (NASDAQ:BLTE) with a Buy and maintains $59 price target.

Earnings Scheduled For November 14, 2023
11/14/2023 13:23:43

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

Belite Bio Q3 EPS $(0.40) Down From $(0.10...
11/14/2023 02:06:01

Belite Bio (NASDAQ:BLTE) reported quarterly losses of $(0.40) per share. This is a 300 percent decrease over losses of $(0.10) ...

Benchmark Reiterates Buy on Belite Bio, Ma...
11/07/2023 17:18:22

Benchmark analyst Bruce Jackson reiterates Belite Bio (NASDAQ:BLTE) with a Buy and maintains $57 price target.

HC Wainwright & Co. Maintains Buy on Belit...
11/06/2023 16:46:17

HC Wainwright & Co. analyst Yi Chen maintains Belite Bio (NASDAQ:BLTE) with a Buy and raises the price target from $55 t...

Belite Bio Presented Final Data From A 24-...
11/06/2023 13:05:52

Belite Bio Announces NMPA Submission For T...
10/17/2023 20:24:10

Tinlarebant (a/k/a LBS-008) is Belite Bio’s orally administered tablet intended to slow disease progression in patients affecte...

Why 22nd Century Group Are Trading Lower B...
08/14/2023 16:49:49

Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into...

Expert Ratings for Belite Bio
08/10/2023 19:00:49

HC Wainwright & Co. Reiterates Buy on Beli...
08/10/2023 11:17:23

HC Wainwright & Co. analyst Yi Chen reiterates Belite Bio (NASDAQ:BLTE) with a Buy and maintains $55 price target.

Earnings Scheduled For August 9, 2023
08/09/2023 08:54:09

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earnings at $0.96 per share on r...